Search
Foghorn Therapeutics Inc.
FHTXAdd to Watchlist
4.180USD
+0.030+0.72%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
245.42MMarket Cap
LossP/E TTM
Foghorn Therapeutics Inc.'s Company Valuation
Currency: USD Updated: 2026-06-22The current valuation score of Foghorn Therapeutics Inc. is 8.06, ranking 173 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.59, which is -66.75% below the recent high of -1.19 and -65.00% above the recent low of -5.92.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
